{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:27:18Z","timestamp":1671204438857},"reference-count":54,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.03.061","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T20:22:36Z","timestamp":1428783756000},"page":"3056-3064","source":"Crossref","is-referenced-by-count":3,"title":["Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis : Conference proceedings"],"prefix":"10.1016","volume":"33","member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.061_bib0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1164\/rccm.200607-923ED","article-title":"Here today \u2013 gone tomorrow: the case for transient acute tuberculosis infection","volume":"174","author":"Nardell","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0280","first-page":"36","article-title":"Tuberculin conversion in the naturally infected guinea pig","volume":"106","author":"Mills","year":"1960","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tube.2007.12.003","article-title":"Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model","volume":"88","author":"Palanisamy","year":"2008","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2011.03.002","article-title":"Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis","volume":"91","author":"Dharmadhikari","year":"2011","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","article-title":"Eliminating latent tuberculosis","volume":"17","author":"Young","year":"2009","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0300","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM198612183152502","article-title":"Exogenous reinfection with tuberculosis in a shelter for the homeless","volume":"315","author":"Nardell","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0305","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJMe1105555","article-title":"What is thwarting tuberculosis prevention in high-burden settings","volume":"365","author":"Nardell","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.03.061_bib0315","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1093\/clinids\/11.Supplement_2.S385","article-title":"What animal models can teach us about the pathogenesis of tuberculosis in humans","volume":"11","author":"Smith","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0320","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/650529","article-title":"High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis","volume":"201","author":"Glynn","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0325","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3201\/eid1211.051207","article-title":"The study recurrent tuberculosis and exogenous reinfection, Shanghai, China","volume":"12","author":"Shen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0330","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0335","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.aje.a116498","article-title":"Interpretation and estimation of vaccine efficacy under heterogeneity","volume":"136","author":"Halloran","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0340","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1473-3099(07)70291-8","article-title":"Measuring tuberculosis burden, trends, and the impact of control programmes","volume":"8","author":"Dye","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0350","first-page":"984","article-title":"Modeling the economic benefits of better TB vaccines","volume":"5","author":"Bishai","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0355","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0360","doi-asserted-by":"crossref","first-page":"e83526","DOI":"10.1371\/journal.pone.0083526","article-title":"Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa \u2013 implications for clinical trials: a decision analysis","volume":"9","author":"Ditkowsky","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0365","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","article-title":"Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Morrison","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0370","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(05)67534-4","article-title":"Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study","volume":"366","author":"Soysal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0375","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/00039896.1968.10665011","article-title":"The epidemiology of tuberculosis infection in a closed environment","volume":"16","author":"Houk","year":"1968","journal-title":"Archiv Environ Health"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0380","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","article-title":"Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak","volume":"361","author":"Ewer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0385","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0390","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7326\/0003-4819-10-2-156","article-title":"Tuberculosis among student nurses: a five year study at Bellevue Hospital","volume":"10","author":"Amberson","year":"1936","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0395","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1084\/jem.20090892","article-title":"Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis","volume":"206","author":"Cobat","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0400","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0405","first-page":"1","article-title":"Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study","author":"Arnedo-Pena","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0410","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"Capuano","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0420","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/IAI.01599-13","article-title":"Early changes by 18Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"82","author":"Coleman","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0430","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1440-1843.2012.02176.x","article-title":"Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis","volume":"17","author":"Walter","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0435","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1128\/CVI.05127-11","article-title":"Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells","volume":"18","author":"Ordway","year":"2011","journal-title":"Clin Vacc. Immunol"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tube.2011.04.001","article-title":"T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis","volume":"91","author":"Henao-Tamayo","year":"2011","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0445","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.20080353","article-title":"Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection","volume":"205","author":"Gallegos","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0450","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0455","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0460","doi-asserted-by":"crossref","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0465","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0470","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/infdis\/jiu446","article-title":"Tuberculin skin test negativity is under tight genetic control of chromosomal region 11p 14-15 in settings with different tuberculosis endemicities","volume":"211","author":"Cobat","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0475","first-page":"1","article-title":"Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection \u2013 2010 update","volume":"201","author":"Committee","year":"2010","journal-title":"Canad Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0480","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.micinf.2007.02.021","article-title":"CXCL10\/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7","volume":"9","author":"Ruhwald","year":"2007","journal-title":"Microbes Infect Inst Pasteur"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0485","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.00129412","article-title":"Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper","volume":"42","author":"Aabye","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0490","series-title":"22nd European congress of clinical microbiology and infectious diseases","article-title":"Sensitivity and specificity of a point-of-care test measuring IP-10 for the diagnosis of active tuberculosis","author":"Lange","year":"2012"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0495","doi-asserted-by":"crossref","first-page":"e105628","DOI":"10.1371\/journal.pone.0105628","article-title":"Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots","volume":"9","author":"Blauenfeldt","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0500","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/erm.11.97","article-title":"IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions","volume":"12","author":"Ruhwald","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0510","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00148308","article-title":"T-cell interferon-\u03b3 release assays: can we do better","volume":"32","author":"Lalvani","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0515","series-title":"Administration USFaD","article-title":"Public Health Service Act","author":"Administration USFaD","year":"1999"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0520","series-title":"Administration UFaD","article-title":"Labeling","author":"Administration UFaD","year":"2014"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0525","series-title":"Administration UFaD","article-title":"Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity","author":"Administration UFaD","year":"2011"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0535","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON(R)-TB gold in-tube conversion and reversion in a cohort of south african adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.03.061_bib0540","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents","author":"Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T15:02:06Z","timestamp":1537714926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":54,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15003801"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}